RankingsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Gross profit

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥1.13T
P/E ratio
12.3x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 2025245,395+30.54%
Mar 31, 2024187,981-50.09%
Mar 31, 2023376,625-6.52%
Mar 31, 2022402,908+6.54%
Mar 31, 2021378,179+7.11%
Mar 31, 2020353,059+2.12%
Mar 31, 2019345,714+87.37%
Mar 31, 2018184,511-40.78%
Mar 31, 2017311,560+4.29%
Mar 31, 2016298,736+10.58%
Mar 31, 2015270,142

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)